Canada
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
53.21%
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
2 |
20.43%
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
|
3 |
17.05%
|
March 31, 2024 | USD 2.65 | -1.93% |
|
Canada |
|
4 |
12.46%
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
5 |
-12.06%
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
|
6 |
-15.87%
|
Dec. 31, 2023 | USD 2.85 | 2.89% |
|
Canada |
|
7 |
-35.92%
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
8 |
-158.79%
|
Dec. 31, 2023 | USD 14.60 | -0.95% |
|
Canada |
|
9 |
-223.48%
|
Dec. 31, 2023 | USD 1.22 | 2.52% |
|
Canada |
|
10 |
-372.01%
|
Dec. 31, 2023 | USD 6.23 | -0.19% |
|
Canada |
|
11 |
-505.35%
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
12 |
-1,146.05%
|
Dec. 31, 2023 | USD 0.15 | -5.56% |
|
Canada |
|
13 |
-5,684.50%
|
Dec. 31, 2023 | USD 1.97 | -2.48% |
|
Canada |
|
14 |
-18,979.61%
|
Dec. 31, 2023 | USD 2.34 | -2.50% |
|
Canada |
|
15 |
-37,154.53%
|
March 31, 2024 | USD 1.14 | 2.02% |
|
Canada |
The Biotechnology company in Canada with the highest EBITDA Margin is Cipher Pharmaceuticals Inc. (Toronto Stock Exchange: CPH.TO) at 53.21%.
The Biotechnology company in Canada with the lowest EBITDA Margin is Zentek Ltd. (TSXV: ZEN.V) at -37,154.53%.
The top 10 Biotechnology companies in Canada by EBITDA Margin are Cipher Pharmaceuticals Inc., HLS Therapeutics Inc., Medexus Pharmaceuticals Inc., Knight Therapeutics Inc., Theratechnologies Inc., Sunshine Biopharma, Inc., Aurinia Pharmaceuticals Inc., Zymeworks Inc., Repare Therapeutics Inc. and Profound Medical Corp..
The bottom 10 Biotechnology companies in Canada by EBITDA Margin are Zentek Ltd., AgriFORCE Growing Systems Ltd., Milestone Pharmaceuticals Inc., Ondine Biomedical Inc., AbCellera Biologics Inc., Profound Medical Corp., Repare Therapeutics Inc., Zymeworks Inc., Aurinia Pharmaceuticals Inc. and Sunshine Biopharma, Inc..